[预订]Treating ADHD in Children and Adolescents 已售少于100 ￥572点击查看更多配送: 北京至 北京市东城区 快递: 7.00预售,付款后42天内发货 保障:7天无理由退货 破损包退查看更多 用户评价 参数信息 图文详情 本店推荐 用户评价 参数信息 ISBN编号 9781462545148 作者 Russell A. Barkley 出版时间 2022-05-...
The article reports on a new clinical trial showing that guanfacine extended release (GXR) is superior to a placebo in improving hyperactivity, impulsivity and inattentiveness in children and adolescents with attention deficit hyperactivity disorder (ADHD). Side effects of GXR were generally mild and ...
The ADHD prevalence was once estimated to be 3 to 5% of school-age children [1], but more recent studies place the figure closer to 7 to 8% of school-age children [2] and 4 to 5% of adults [3]. Prevalence clearly varies, with risk factors including age, male gender, chronic health...
The ADHD prevalence was once estimated to be 3 to 5% of school-age children [1], but more recent studies place the figure closer to 7 to 8% of school-age children [2] and 4 to 5% of adults [3]. Prevalence clearly varies, with risk factors including age, male gender, chronic health...
ADHD in children and adolescents. Prevalence estimates of attention deficit hyperactivity disorder (ADHD) vary according to the diagnostic criteria used and the population sampled. DSM-IV prevalence estimates among school children in the US are 3% to 5%, but other estima... D Keen,I Hadijikoumi...
ADHD in children and adults: diagnosis and prognosis. Attention-deficit hyperactivity disorder (ADHD) is one of the most common neuropsychiatric disorders with childhood onset, having a chronic course associat... R Kieling,LA Rohde - 《Current Topics in Behavioral Neurosciences》 被引量: 40发表: ...
Children taking a prescription stimulant to manage symptoms of attention deficit hyperactivity disorder (ADHD) do not have more substance use or substance use disorder (SUD) as adolescents or young adults, according to a new study by researchers at the University of Pittsburgh School of Medicine. ...
Sixty children and adolescents with tic disorder were randomly allocated into one of the two groups to receive either aripiprazole or risperidone for 2 months. The primary outcome measure was the score of Yale Global Tic Severity Scale. In addition, health related quality of life and adverse ...
are no U.S. guidelines for diagnosing and evaluating the disorder in adults, said Dr. David Goodman, an assistant professor in psychiatry and behavioral sciences at the Johns Hopkins School of Medicine. Instead, such guidelines only exist for treating the condition in children and adolescents. ...
This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) based on th... Pliszka,Steven - 《Journal of the American Academy of Child & Adolescent Psychiatry》 被引量: 748发表: 2007年 American Academy of Child and...